Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-low dose oral ketamine for chronic non-cancer pain
NCT02303847Phase 3Unknown
- Sponsor
- University of Washington
- Start
- Nov 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in Chronic non-cancer pain (CNCP), sponsored by University of Washington. Status: unknown.
02
Drugs
ketamine
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on NCT02303847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303847.